{"id":63021,"date":"2026-04-29T04:02:43","date_gmt":"2026-04-29T02:02:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/"},"modified":"2026-04-29T04:02:43","modified_gmt":"2026-04-29T02:02:43","slug":"trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/","title":{"rendered":"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access"},"content":{"rendered":"
\n

HOUSTON–(BUSINESS WIRE)–TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAUNCH digital health accelerator. The company has also opened a $1.5M round to accelerate growth.<\/p>\n

<\/a>
<\/a><\/p>\n

\nFounded by board-certified neurologist and clinical researcher Jontel Pierce, MD, TrialClinIQ is rethinking how patients are matched to clinical trials. The platform connects complex trial criteria with real-world clinical data and automated outreach workflows, enabling sponsors, research sites, and health systems to identify and engage eligible patients faster while improving access to clinical trials.<\/p>\n

\nThe investment and accelerator support will drive product development, expand EHR and data integrations, and launch early pilots with health systems and research partners.<\/p>\n

\n\u201cClinical trials drive innovation, but too many patients are still left out,\u201d said Jontel Pierce, MD, founder and CEO of TrialClinIQ. \u201cWe\u2019re building the infrastructure to connect more patients to clinical trials by essentially decentralizing clinical trial recruitment.\u201d<\/p>\n

\nCaduceus LAUNCH is designed to fast-track high-potential digital health startups through capital, mentorship, and direct access to a national network of healthcare operators and investors. Caduceus Capital Partners invests in early-stage companies positioned to reshape healthcare delivery and outcomes.<\/p>\n

\nTrialClinIQ\u2019s $1.5M raise will support team expansion across engineering and data science, deepen data and EHR partnerships, strengthen security and compliance, and scale commercial efforts with sponsors, CROs, and health systems. The company is seeking investors aligned with digital health innovation and equitable access to care.<\/p>\n

\nAbout TrialClinIQ<\/p>\n

\nTrialClinIQ is a Houston-based digital health company transforming clinical trial recruitment through AI-driven patient matching. By connecting trial protocols with real-world clinical and demographic data, the platform helps research stakeholders identify eligible participants faster while improving access for historically underrepresented populations.<\/p>\n

\nAbout Caduceus Capital Partners<\/p>\n

\nCaduceus Capital Partners is a venture capital firm focused on backing early-stage digital health companies with capital, strategic guidance, and access to a national network of healthcare leaders.<\/p>\n

Contacts<\/b> <\/p>\n

\nJontel Pierce, M.D. email: jontel@trialcliniq.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HOUSTON–(BUSINESS WIRE)–TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAUNCH digital health accelerator. The company has also opened a $1.5M round to accelerate growth. Founded by board-certified neurologist and clinical researcher Jontel Pierce, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63021","6":"format-standard","7":"category-industry"},"yoast_head":"\nTrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HOUSTON–(BUSINESS WIRE)–TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAUNCH digital health accelerator. The company has also opened a $1.5M round to accelerate growth. Founded by board-certified neurologist and clinical researcher Jontel Pierce, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-29T02:02:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260428735913\/en\/2788684\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access\",\"datePublished\":\"2026-04-29T02:02:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/\"},\"wordCount\":353,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260428735913\\\/en\\\/2788684\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/\",\"name\":\"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260428735913\\\/en\\\/2788684\\\/22\\\/logo.jpg\",\"datePublished\":\"2026-04-29T02:02:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260428735913\\\/en\\\/2788684\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260428735913\\\/en\\\/2788684\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/","og_locale":"en_US","og_type":"article","og_title":"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access - Pharma Trend","og_description":"HOUSTON–(BUSINESS WIRE)–TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAUNCH digital health accelerator. The company has also opened a $1.5M round to accelerate growth. Founded by board-certified neurologist and clinical researcher Jontel Pierce, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-29T02:02:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260428735913\/en\/2788684\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access","datePublished":"2026-04-29T02:02:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/"},"wordCount":353,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260428735913\/en\/2788684\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/","url":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/","name":"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260428735913\/en\/2788684\/22\/logo.jpg","datePublished":"2026-04-29T02:02:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260428735913\/en\/2788684\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260428735913\/en\/2788684\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/trialcliniq-raises-150k-from-caduceus-capital-joins-launch-accelerator-and-opens-1-5m-round-to-transform-clinical-trial-access\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63021"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63021\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}